Terminally ill rodents with type 1 diabetes have been restored to full health with a single injection of a substance other than insulin by scientists at UT Southwestern Medical Center.

A recent study sheds new light on the standard hospital practice of glucose control. The study indicates that for critically ill patients, striving to keep blood glucose at normal levels doesn’t significantly reduce risk of death in the hospital, and actually increases the risk of low blood sugar.

The first patient in the New York City area received incision-free surgery for obesity.

In case you’ve escaped the sensationalist media reports about the Byetta-pancreatitis issue, this week the FDA issued a new warning after six cases of necrotizing pancreatitis in Byetta users came to light. Overall, the numbers are small. The annual rate of pancreatitis among people not on Byetta is about 17 …

Janesha O. Womack, Doctor of Pharmacy Candidate, FAMU College of Pharmacy has used the new Nutritional Concepts Meal Planning software and now knows exactly how to get glucose under control. She shares her experience with us. To read the feature on this product and get a free 30 day trial: …

Medications for blood pressure called beta blockers—like atenolol, propanolol and metaprolol— could be an unacceptable risk for diabetes.

Fenofibrate in combination with coenzyme Q10 (CoQ) appears to have a number of beneficial effects in type 2 diabetic subjects with mild left ventricular (LV) diastolic dysfunction, researchers report.

According to findings from a Swedish study, the risk of non-traumatic lower-extremity amputation remains high among patients with type 1 diabetes.

A snapshot of the retina could detect cell damage in the early stages of diabetes. Diabetics can lose “a substantial fraction–up to 50 percent–of their retinal cells” before they’re aware of vision problems.

Aggressive diabetes risk management appears to have lessened the rate of stroke and mortality for the first time for these patients, researchers found.